Review
Copyright ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Transplant. Dec 24, 2016; 6(4): 632-645
Published online Dec 24, 2016. doi: 10.5500/wjt.v6.i4.632
Complement related kidney diseases: Recurrence after transplantation
Maurizio Salvadori, Elisabetta Bertoni
Maurizio Salvadori, Elisabetta Bertoni, Department of Renal Transplantation, Careggi University Hospital, 50139 Florence, Italy
Author contributions: Salvadori M wrote the manuscript; Salvadori M and Bertoni E researched literature data and reviewed the manuscript.
Conflict-of-interest statement: No conflict of interest for both authors as in the enclosed declaration.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Maurizio Salvadori, MD, Department of Renal Transplantation, Careggi University Hospital, viale Pieraccini 18, 50139 Florence, Italy. maurizio.salvadori1@gmail.com
Telephone: +39-055-597151 Fax: +39-055-597151
Received: September 12, 2016
Peer-review started: September 13, 2016
First decision: October 21, 2016
Revised: October 26, 2016
Accepted: November 16, 2016
Article in press: November 16, 2016
Published online: December 24, 2016
Processing time: 92 Days and 15.8 Hours
Core Tip

Core tip: Complement cascade is an important pathway of several kidney diseases. A distinction should be made between kidney diseases with complement overactivation and those with complement dysregulation. The latter are related to congenital or acquired abnormalities of complement factors. These diseases are linked to constitutional abnormalities of the patients, have high recurrence rate after renal transplantation and represent an important cause of graft loss. Diagnosis and treatment are not easy to be made. Just in the last decade a growing knowledge in the field of genetic and biology allowed the complement inhibitors to be the first class drug in the treatment.